Download FREE Report Sample
Download Free sampleDecitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).
Decitabine Drug Market contains market size and forecasts of Decitabine Drug in Global, including the following market information:
Global Decitabine Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Decitabine Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dacogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Decitabine Drug include Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical, Cipla and Lupin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Decitabine Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decitabine Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Decitabine Drug Market Segment Percentages, by Type, 2021 (%)
Dacogen
Generic
Global Decitabine Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Decitabine Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug store
Global Decitabine Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Decitabine Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decitabine Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Decitabine Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
